Charity Registration No. 1175427
PSC SUPPORT TRUSTEES' REPORT AND ACCOUNTS FOR THE YEAR ENDED 5 APRIL 2024
PSC SUPPORT
CONTENTS FOR THE YEAR ENDED 5 APRIL 2024
REFERENCE AND ADMINISTRATIVE DETAILS
Name PSC SUPPORT Charity registration no. 1175427 Address Unit 23056, UK Postbox PO Box 4336 MANCHESTER M61 0BW Independent Examiner Wenn Townsend Chartered Accountants Victoria House 10 Broad Street Abingdon Oxon OX14 3LH
Trustees serving on the date the report was approved
Tim Waterson (Chair) Harrison Moller Mark Dean Helen Elder Rick Dallaway Nicholas Kane James Brown David Adams Charlene Oke (from 26/6/23)
PSC SUPPORT
CONTENTS FOR THE YEAR ENDED 5 APRIL 2024
| Trustees report | 1-6 |
|---|---|
| Statement of trustees' responsibilities | 7 |
| Independent examiner's report | 8 |
| Statement of financial activities | 9-10 |
| Balance sheet | 11-12 |
| Notes to the accounts | 13-17 |
PSC SUPPORT
TRUSTEES’ REPORT FOR THE YEAR ENDED 5 APRIL 2024
The Trustees present their report and financial statements for the year ended 5 April 2024. The accounts have been prepared in accordance with applicable accounting standards, SORP 2015 (FRS 102) Accounting and Reporting by Charities and the Charities Act 2011.
Structure, governance and management governing document
The charity uses a constitution as its governing document.
PSC Support is a Charitable Incorporated Organisation (CIO)
Trustees use the Charity Governance code as a framework to build and improve governance standards.
Recruitment and appointment of trustees
Trustees are interviewed and then appointed by existing trustees.
Public benefit statement
The Trustees confirm that they have referred to the information contained in the Charity Commission’s general guidance on public benefit when reviewing the charity’s aims and objectives and in planning future activities. As a matter of course, reference is made to our agreed objectives to aid decisionmaking.
Our prioritised short-term goals are as follows:
-
1 Research We will establish a pathway towards finding a cure or effective treatment for PSC
-
2 Information and Support We will provide support and information to improve the quality of life and wellbeing of people affected by PSC
-
3 Improving Care
We will advocate for the highest standards of care for people living with PSC
OBJECTIVES AND ACTIVITIES
Our charitable objects are:
-
1 The relief of those suffering from liver diseases or disorders (in particular but without limitation PSC), and related disorders
-
2 The advancement of public awareness of PSC, other liver disease and related disorders 3 The advancement of both the treatment and prevention of PSC and other liver disease and related disorders.
Our related activities include (but are not limited to) the following:
-
Funding high quality research, helping to shape clinical and other research trials and funding co-applicants for PSC research
-
Providing high-quality, medically checked information on our website, social media, newsletters and at PSC Support events
-
Providing support for those affected by PSC via our Helpline service and our moderated, private PSC Support Facebook group
-
Advocating for those affected by PSC both in the UK and internationally.
1
PSC SUPPORT
TRUSTEES’ REPORT FOR THE YEAR ENDED 5 APRIL 2024
ACHIEVEMENTS AND PERFORMANCE
Fundraising/ Income
The charity received a total income of £405,606 including £381,601 from fundraising, donations and merchandise sales for the year ending 5th April 2024. Fundraising income was again dramatically up on the previous year with a 54% increase. While the general economy remains difficult this increase is a testament to our work and our supporters who are motivated by our charity’s aims and objectives, particularly in relation to funding high quality research. £90,576 of the total was in restricted income which was broken down as £10,426 for Information Days, £21,225 for a new e-learning platform on PSC guidelines and £58,925 for PSC research.
Expenditure
PSC Support trustees place the utmost importance on spending the charity’s money best possible way for our beneficiaries. Our expenditure in this FY was £308,593 up from £127,077 the previous year. Research funding, an additional staff member, freelance support and bolstering our back-office systems including fundraising accounted for this rise in our expenditure.
Staff
The charity recruited a new member of staff during the year. Mark Chatterley became the new Administration Manager and has proved to be a great asset to the charity.
Martine Walmsley become our new Head of Research Strategy in line with her strengths and significant experience in this area of work.
Volunteers
Our volunteers make an immense contribution to the charity and trustees recognise their pivotal role.
In particular they would like to recognise the following: Keith Anderson, the charity’s long-standing Treasurer, who resigned after 12 years of service during the financial year and Facebook moderator Lorraine Failes another long-standing volunteer for the charity.
They are also very grateful to long term Facebook moderators Vicki and Gareth Weeks and Josie and Malcolm Eddy who manage merchandise and assist with fundraising. Trustees would also like to recognise the contribution made by our webmaster Iain McClenaghan and Noelie Srivastava for her graphic design services.
Trustees would like to recognise all those affected by PSC who have provided different perspectives in this year’s support, advocacy and research initiatives. As well as being a Facebook moderator Gareth Weeks also sits alongside Chris Forde, Jenny Nelson and Gary Taylor as patient representatives on our Expert Panel; they all play a crucial role in this capacity. Additionally, Gareth Weeks and Chris Forde are also lay members of our Scientific Review Committee.
PSC Support works with dedicated medical professionals, who give their time and expertise to PSC Support at no cost. This year, we are grateful for support from:
Professor David Adams Professor Doug Thorburn Professor Annika Bergquist Professor Angsar Lohse
2
PSC SUPPORT
TRUSTEES’ REPORT FOR THE YEAR ENDED 5 APRIL 2024
Professor Catherine Williamson Professor Shaid Khan Professor Alaistair O’Brien Dr Palak Trivedi Dr Roger Chapman Dr Deepak Joshi Dr Simon Rushbrook Dr Emma Culver Dr Luke Boulter Dr Richard Aspinall Dr James Ferguson Dr Jess Dyson Dr Andrew Yeoman Dr Kate Lynch Dr Francesca Saffioti Dr Christoph Schramm Dr Brijesh Srivastava Dr Nora Cazzagon Dr Norman Junge Dr George Mells Dr Amera Elzubeir Dr Nicholas Ilott
Fundraising Products
20K Your Way was a new fundraising product designed to engage our community more and provide another way to fundraise for the charity. This campaign produced over £22k in revenue for the charity in its first year and will now become an annual fundraising campaign.
Support from the Pharmaceutical Industry
The following companies sponsored Information Days:
-
Mirum Pharmaceuticals
-
Chemomab Therapeutics
-
Dr Falk Pharma UK
While we are incredibly grateful for their financial support, these companies have had no influence over content or the agendas of the events.
Information and Support
Social media – the charity has over 10k followers across all social media platforms. We post daily to engage with the community and to provide up to date information. Our well-moderated private Facebook group of over 4,000 people offers peer support. Huge thanks go to our volunteer moderators and staff moderator, Martine Walmsley, who work tirelessly to make sure the private support group is moderated to a very high standard even during holiday periods.
Ask the Experts – Over 700 people attended our webinars which were scheduled as monthly events in the second half of the financial year. These events gave those affected by PSC access to expert clinicians, helped them find out the latest developments and ask questions about PSC and related conditions.
3
PSC SUPPORT
TRUSTEES’ REPORT FOR THE YEAR ENDED 5 APRIL 2024
Information Days – we delivered one face-to-face event in this financial year in Oxford. 105 people attended the event (despite a national train strike) and we received excellent feedback. Attendees rated the event 4.9 out of 5.
‘I thoroughly enjoyed the event and catching up with others or finally meeting some of those I've only known through the Facebook group. There was a great mix of speakers and either personal experiences or medical information, for those newly diagnosed and those pre or post-transplant. The panel discussion sounded interesting too from the feedback and good to have a wellbeing session. Well done to you and the volunteers who helped make the day possible, they are so valuable for PSCers. Thank you.’
Helpline – We had over 100 emails to or calls to our Helpline. Special thanks to Martine Walmsley who has managed this service for a number of years. We receive excellent feedback from those who have accessed the helpline and they were very grateful for her support.
'Thank you so much for listening to me talk and addressing my worries and concerns'
Research (including publications)
PSC research remains a priority for the charity. We launched a new research campaign called Mission 2030 in an attempt to do everything we can to find an effective treatment for PSC. This campaign committed to fund £1 million worth of research by 2030. Funding will include research projects and a Research Training Fellowship.
Mission 2030 includes:
-
Annual research project funding of minimum of £80,000 per annum
-
Research Training Fellowship funding for three years for 2024-27; total funding of £300,000
We were delighted to agree funding for five research projects in the first year of the campaign with a total value of £207,500.
The charity also continued to dedicate time to support clinical trial development by working with pharmaceutical companies to ensure trial protocols and patient information were fit for purpose and appropriate for our UK community.
Additional research activities included:
-
Being a co-applicant on national and international PSC research study funding applications
-
Representing people with PSC on trial steering committees and trial management groups for national research projects, studies and trials.
-
Running focus groups of 8-10 people living with PSC each to provide patient and public involvement to inform academic research studies. We are very grateful to the people with PSC who joined our research panels to provide feedback to researchers.
-
Representing PSC patients in the European Reference Network (ERN RARE-LIVER) as the Co-Lead of the PSC Working Group (MW).
Publications:
1. Rushbrook S, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, Sturgess R, Davidson B, Malik H, Manas D, Heaton N. British Society of Gastroenterology Guidelines for the Diagnosis and Management of Cholangiocarcinoma. Gut. 2023 Sep 5.
- Hussain N, Hirschfield B, Ferguson J, Abbas N, Bhandal K, Rogers P, Burke E, Hull D,
4
PSC SUPPORT
TRUSTEES’ REPORT FOR THE YEAR ENDED 5 APRIL 2024
Gungabissoon U, Casillas L, Mukherjee S. P34 Burden, impact and variability of pruritus i primary sclerosing cholangitis (PSC) over time: a prospective observational study. Gut. 2023 72 S3
3. Walmsley M, Tornai D, Cazzagon N, Leburgue A, Mrzljak A, Lenzen H, Carbone M, ‐
Madaleno J, Lleo A, Junge N, Schramm C, Bergquist, A. Patient reported quality of care in primary sclerosing cholangitis. Liver International. 2023 Jun 13
4. Hussain N, Hirschfield B, Ferguson J, Abbas N, Bhandal K, Rogers P, Burke E, Hull D, Gungabissoon U, Casillas L, Mukherjee S. Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study. Journal of Hepatology. 2023. Jun. 78, SUPPLEMENT 1, S398-S399
5. Bergquist A, Walmsley M, Tornai D, Cazzagon N, Leburgue A, Mrzljak A, Lenzen H, Carbone M, Madaleno J, Lleo A, Junge N. Patient reported gaps between current practice and new practice guidelines for primary sclerosing cholangitis. Journal of Hepatology. 2023 Jun 1;78:S383-4
6. Kowdley KV, Safer R, Gomel R, Hatchett J, Walmsley M, Burman JA, Weinbaum S, Goldsmith K, Garner W, McKibben A, Chien E. Tu1587 IMPACT OF PRURITUS IN PRIMARY SCLEROSING CHOLANGITIS (PSC) FROM THE PATIENT PERSPECTIVE: A MULTI-NATIONAL STUDY. Gastroenterology. 2023 May 1;164(6):S-1426
Advocacy
PSC Support continued to provide strong advocacy for those affected by PSC both at a national and international level.
Organisational Risk, Limitations and Stability
PSC Support Trustees continued to hold quarterly meetings and kept in close contact with the CEO during the year.
The Board receives a full Financial Report every quarter, which takes into account the forecast, expenditure, income and any designated funds to ensure they are fully aware of the charity’s current and expected financial position as an ongoing concern.
The staff base increased with the appointment of the Administration Manager.
During the financial year the charity moved its accounts onto the accountancy software package, Xero.
FINANCIAL REVIEW
The detailed accounts for the year ended 5 April 2024 are shown on pages 10-20. The accounts show that at the end of the financial year PSC Support held £639,187 in funds. This was broken down as total unrestricted £617,412 and total restricted £21,775.
At the end of the financial year the charity held £43,500 of committed funds for research.
No funds were materially in deficit.
Policy on reserves
5
PSC SUPPORT
TRUSTEES’ REPORT
FOR THE YEAR ENDED 5 APRIL 2024
In 2023-24 reserves contingency was nine months operating costs. These reserves would enable normal operating activities to continue over a period of 9 months should a shortfall in income occur. It also takes into account any potential risks and contingencies that may arise from time to time.
In order to establish the reserve, the Trustees consider the financial circumstances and risks annually (expenditure and unrestricted income).
The Trustees review the charity accounts on a quarterly basis.
The Trustees regularly reviewed funds/reserves levels throughout 2023/24, focusing funds on the most important priorities.
The reserves value held by the charity (which equals 9 months of running costs), stands at £134,162. This includes the increased pay expenditure allocated to new staff.
Future plans
These include the following:
-
The continued funding of high-quality research as part of the Mission 2030 campaign.
-
Producing two in person Information Days a year in different locations to ensure PSC experts are accessible to those affected by PSC
-
The development of an e-learning platform for doctors and nurses to increase their knowledge about the PSC guidelines
-
The production of an infographic patient journey on the PSC Support website and a general update of the website
-
Moving to a nurse managed helpline
Independent Examiner
A resolution will be proposed at the Trustee Meeting that Wenn Townsend be re-appointed as Independent Examiner to the charity for the ensuing year.
Approved by the Trustees and signed on their behalf on 22[nd] January 2025 by:
----- Start of picture text -----
…………………..
----- End of picture text -----
Tim Waterson (Trustee)
6
PSC SUPPORT
STATEMENT OF TRUSTEES' RESPONSIBILITIES
The trustees are responsible for preparing the Trustees' Report and the accounts in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England and Wales requires the trustees to prepare accounts for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that year.
In preparing these accounts, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP;
-
make judgements and estimates that are reasonable and prudent;
-
state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the accounts; and
-
prepare the accounts on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.
The trustees are responsible for keeping sufficient accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the accounts comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
7
PSC SUPPORT
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF PSC SUPPORT
I report to the charity trustees on my examination of the accounts of the charity for the year ended 5 April 2024 which are set out on pages 9-17.
Responsibilities and basis of report
As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants of England and Wales, which is one of the listed bodies.
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the Act; or
-
the accounts do not accord with those records or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Stuart Bates FCA CTA Wenn Townsend 10 Broad Street Abingdon OX14 3LH
……………………….. 28 January 2025
8
PSC SUPPORT
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 5 APRIL 2024
| Unrestricted funds Notes £ Income Donations and legacies 263,648 Grants 2 - Investment income 3 15,410 Gift aid 29,967 Other charitable activities 6,005 Total 315,030 Expenditure Research payable - Fundraising 22,286 Direct charitable expenditure 142,654 Governance costs 13,943 Total 4 178,883 Net Income (Expenditure) 136,147 Transfers between funds (21,137) Net movement in funds 115,010 Fund balances at 5 April 2023 502,402 Fund balances at 6 April 2024 617,412 |
Restricted funds £ 34,454 31,651 - 6,471 18,000 90,576 86,000 - 43,710 - 129,710 (39,134) 21,137 (17,997) 39,772 21,775 |
Total 2024 Total 2023 £ £ 298,102 242,667 31,651 550 15,410 2,223 36,438 16,928 24,005 1,319 |
Total 2024 Total 2023 £ £ 298,102 242,667 31,651 550 15,410 2,223 36,438 16,928 24,005 1,319 |
|---|---|---|---|
| 405,606 | 263,687 |
||
| 86,000 22,286 186,364 13,943 |
8,542 3,925 114,010 600 |
||
| 308,593 | 127,077 |
||
| 97,013 136,610 - - |
|||
| 97,013 | 136,610 |
||
| 542,174 | 405,564 |
||
| 639,187 | 542,174 |
9
PSC SUPPORT
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 5 APRIL 2023 (COMPARATIVE FIGURES)
| Income Donations and legacies Grants Investment income Gift aid Other charitable activities Total Expenditure Grants payable Fundraising Direct charitable expenditure Governance costs Total Net movement in funds Fund balances at 6 April 2022 Fund balances at 5 April 2023 |
Unrestricted funds £ 216,657 - 2,223 10,678 1,319 230,877 8,504 3,925 114,010 600 127,039 103,838 398,564 502,402 |
Restricted funds £ 26,010 550 - 6,250 - 32,810 38 - - - 38 32,772 7,000 39,772 |
Total 2023 £ 242,667 550 2,223 16,928 1,319 263,687 8,542 3,925 114,010 600 127,077 136,610 405,564 542,174 |
|---|---|---|---|
10
PSC SUPPORT
BALANCE SHEET FOR THE YEAR ENDED 5 APRIL 2024
| Notes Fixed Assets Tangible Assets 6 Current Assets Stocks Debtors 7 Cash at Bank and in hand Creditors: amounts falling due within one year 8 Net current assets Total assets less current liabilities Income funds Restricted Funds Unrestricted Funds |
£ 3,119 60,749 581,975 645,843 10,015 |
2024 £ £ 3,359 635,828 639,187 21,775 617,412 639,187 |
2023 £ 2,776 1,162 15,472 525,971 |
2023 £ 2,776 1,162 15,472 525,971 |
|---|---|---|---|---|
542,605 |
||||
3,207 539,398 |
3,207 |
|||
| 542,174 | ||||
39,772 502,402 |
||||
| 542,174 |
The accounts were approved by the Trustees on 22[nd] January 2025
Tim Waterson (Trustee)
………………………………………
11
PSC SUPPORT
BALANCE SHEET FOR THE YEAR ENDED 5 APRIL 2024
1 Accounting policies
1.1 Basis of preparation
The charity constitutes a public benefit entity as defined by FRS 102. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS102), the Charities Act 2011 and applicable regulations.
The charity has applied Update Bulletin 1 as published on 2 February 2016 and does not include a cash flow statement on the grounds that it is applying FRS 102 Section 1A.
PSC Support is a charity in England and Wales. The address of the registered office is given in the charity information contents page of these financial statements.
The financial statements are prepared on a going concern basis under the historical convention (modified to include certain items at fair value). The financial statements are presented in sterling, which is the functional currency of the charity and rounded to the nearest pound.
The financial statements have been prepared under the historical cost convention as modified by the inclusion of investments at market value.
1.2 Incoming resources
Donations, legacies and other forms of voluntary income are recognised as incoming resources when receivable.
1.3 Expenditure and liabilities
Expenditure is accounted for on an accrual basis and recognised at the time the liability is incurred.
1.4 Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:
Fixtures, fittings & equipment 25% straight line
1.5 Investments
Fixed asset investments are stated at market value.
Unrealised gains or losses are recognised each year within the Statement of Financial Activities.
1.6 Stock
Stock is valued at the lower of cost and net realisable value.
1.7 Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted.
1.8 Restricted funds
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the accounts.
12
PSC SUPPORT
NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2024
| 2 Grants Information Days E-Learning Clinical Trials 3 Interest Receivable |
2024 £ 10,426 21,225 - |
2023 £ - 550 |
|
|---|---|---|---|
| 31,651 | 550 | ||
| 15,410 | 2,223 |
13
PSC SUPPORT
NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2024
| 4 Total resources expended Grants Restricted funds Unrestricted funds Direct charitable expenditure Salaries unrestricted (including employer NI and pensions) Salaries restricted (including employer NI and pensions) Other Staff costs General administration Advocacy Awareness and Support (unrestricted) Awareness and Support (restricted) Other Depreciation Fundraising Advertising and promotion Merchandise Governance costs Accountancy Legal cost Independent examiner Total resources expended |
Total Total 2024 2023 £ £ 86,000 38 - 8,504 |
|---|---|
| 86,000 8,542 |
|
| 100,597 86,341 31,806 - 12,398 6,409 3,042 3,140 15,994 4,072 9,139 9,845 11,904 - - 3,148 1,484 1,055 |
|
| 186,364 114,010 |
|
| 19,371 2,678 2,915 1,247 |
|
| 22,286 3,925 |
|
| 5,529 - 7,664 - 750 600 |
|
| 13,943 600 |
|
| 308,593 127,077 |
14
PSC SUPPORT
NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2024
5 Trustees
Trustees were reimbursed a total of £358.48 during the year for travel expenses (2023: £122).
£
6 Fixed Assets
| Cost at 6 April 2023 Purchases at cost Cost at 5 April 2024 Depreciation at 6 April 2023 Charge for the year Depreciation at 5 April 2024 Net book value at 5 April 2024 Net book value at 5 April 2023 7 Debtors Accrued income Prepayments Other Debtors 8 Creditors: amounts falling due within one year Aged creditors Accruals |
2024 £ 55,712 1,855 3,182 |
4,680 2,067 |
|---|---|---|
| 6,747 | ||
| 1,904 1,484 |
||
| 3,388 | ||
| 3,359 | ||
| 2,776 | ||
| 2023 £ 15,448 24 - |
||
| 60,749 | 15,472 | |
| 2024 £ 6,260 3,755 |
2023 £ - 3,027 |
|
| 10,015 | 3,027 |
15
PSC SUPPORT
NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2024
9 Restricted Funds
| PSC Research Information Days Education As 5 April 2024 PSC Research Education As 5 April 2023 |
Movement in funds Balance at 6 April 2023 Incoming Resources & Transfers Outgoing Resources & Transfers Balance at 5 April 2024 £ £ £ £ 39,222 78,584 117,806 - - 11,904 11,904 - 550 21,225 - 21,775 |
|---|---|
| 39,772 111,713 129,710 21,775 |
|
| Balance at 6 April 2022 Incoming Resources & Transfers Outgoing Resources & Transfers Balance at 5 April 2023 £ £ £ £ 7,000 32,260 38 39,222 - 550 - 550 |
|
| 7,000 32,810 38 39,772 |
Description of restricted funds
Research – to be spent on research projects relating to PSC.
Information Days – to be spent on events to support and inform people with PSC and their support networks
Education – Educational PSC project for medical practitioners
10
16
PSC SUPPORT
NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2024
Analysis of net assets between funds
| Unrestricted Funds £ Fund balances at 5 April 2024 are represented by: Fixed assets 3,359 Current assets 624,068 Creditors: amounts falling due within one year (10,015) 617,412 11 Commitments At 5 April 2024 the charity had committed funds Research 12 Employees During the year 2023-24 there were 4 employees (During the year 2022-23 there were 3 employee) Salary costs including NI Pension No employees received employee benefits (excluding employer pension costs) of more than £60,000. |
Unrestricted Funds £ 3,359 624,068 (10,015) |
Restricted Funds Total Funds £ £ - 3,359 21,775 645,843 - (10,015) |
|---|---|---|
| 617,412 | 21,775 639,187 |
|
| 2024 2023 £ £ 43,500 53,000 |
||
| 43,500 53,000 |
||
| 2024 2023 £ £ 126,447 82,564 5,956 3,777 |
||
| 132,403 86,341 |
||
17